Page 3 - Indian (NIFTY) Growth Pharmaceuticals & Biotech Stocks

UPDATED Aug 31, 2024

Discover Indian Pharmaceuticals & Biotech Growth Stocks that are on the NIFTY. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

200 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

524669

Hester Biosciences
₹2,366.20-4.4%37.5%₹20.1bn/aPE104xn/a0.3%

SUNREST

Sunrest Lifescience
₹59.50-1.7%n/a₹255.3mn/aPE113.1xn/an/a

524590

Hemo Organic
₹13.5926.2%110.7%₹47.1mn/aPS208.4xn/an/a

524518

Krebs Biochemicals & Industries
₹83.20-1.4%23.6%₹1.8bn/aPS3.4xn/an/a

537253

Sunil Healthcare
₹95.043.3%79.3%₹974.6mn/aPS1.1xn/an/a

524824

Bal Pharma
₹146.403.4%51.5%₹2.3bn/aPE30.4xn/a0.8%

526853

Bilcare
₹66.18-6.0%-10.0%₹1.6bn/aPB0.3xn/a0%

524400

Ishita Drugs and Industries
₹83.220.5%22.4%₹248.9mn/aPE32.8xn/an/a

524731

Jenburkt Pharmaceuticals
₹1,111.451.5%58.1%₹4.9bn/aPE17.5xn/a1.4%

590006

Amrutanjan Health Care
₹819.408.5%34.1%₹23.7bn/aPE55.6xn/a0.6%

WINDLAS

Windlas Biotech
₹819.800.7%111.0%₹17.1bn/aPE28.7xn/a0.7%

524572

Pharmaids Pharmaceuticals
₹43.620.3%12.2%₹1.5bn/aPS7.6xn/an/a

524314

Gujarat Terce Laboratories
₹58.6120.9%239.8%₹434.9mn/aPE29.5xn/an/a

BAFNAPH

Bafna Pharmaceuticals
₹80.68-0.3%-21.3%₹1.9bn/aPE698.6xn/an/a

530549

Shilpa Medicare
₹768.0510.2%107.0%₹66.7bn/aPE149xn/a0%

530239

Suven Life Sciences
₹142.55-5.7%119.5%₹31.1bn/aPS349.2xn/a0%

539730

Fredun Pharmaceuticals
₹783.55-1.6%-21.2%₹3.7bn/aPE21.2xn/a0.09%

531541

Kobo Biotech
₹3.07-1.9%4.1%₹73.1mn/aPE-1.5xn/a0%

532039

Zenotech Laboratories
₹70.484.3%30.2%₹4.3bn/aPE57.7xn/an/a

530199

Themis Medicare
₹252.30-5.0%58.7%₹23.2bn/aPE46.4xn/a0.2%

538634

Vasundhara Rasayans
₹305.45-2.1%43.6%₹970.8mn/aPE16.8xn/a0.7%

539267

Samsrita Labs
₹17.311.0%5.5%₹256.3mn/aPB2.1xn/an/a

538965

Concord Drugs
₹36.19-1.6%-0.8%₹361.9mn/aPE3933.7xn/an/a

NECLIFE

Nectar Lifesciences
₹39.107.1%47.8%₹8.8bn/aPE142.7xn/a0%
Page 3 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.